These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2546461)

  • 1. Chronic ACTH treatment increases striatal dopamine D-2 receptor binding in developing rat brain.
    Chiriboga CA; Pranzatelli MR; De Vivo DC
    Brain Dev; 1989; 11(3):197-200. PubMed ID: 2546461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ACTH/MSH-like peptides inhibit the binding of dopaminergic ligands to the dopamine D2 receptor in vitro.
    Florijn WJ; De Boer T; Tonnaer JA; Van Nispen JW; Versteeg DH
    Eur J Pharmacol; 1991 May; 207(1):43-50. PubMed ID: 1680721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Definition of the in-vivo accumulation of [3H]spiperone in brain using haloperidol and sulpiride to determine functional dopamine receptor occupation.
    Chivers JK; Reavill C; Jenner P; Marsden CD
    J Pharm Pharmacol; 1988 Sep; 40(9):613-9. PubMed ID: 2907027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of adrenalectomy and glucocorticoids on rat brain dopamine receptors.
    Biron D; Dauphin C; Di Paolo T
    Neuroendocrinology; 1992 Apr; 55(4):468-76. PubMed ID: 1314340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resolution of dopamine and serotonin receptor components of [3H]spiperone binding to rat brain regions.
    List SJ; Seeman P
    Proc Natl Acad Sci U S A; 1981 Apr; 78(4):2620-4. PubMed ID: 6941314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of 3H-spiperone and 3H-(-)-sulpiride to dopamine D2 receptors in rat striatal membranes: methodological considerations and demonstration of the identical nature of the binding sites for the two ligands.
    Urwyler S; Coward D
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Feb; 335(2):115-22. PubMed ID: 2951601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine D2 and muscarinic receptor binding characteristics in rat brain after withdrawal of subchronic fluphenazine and sulpiride treatment.
    Hietala J; Syvälahti E; Röyttä M
    Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(1-2):247-58. PubMed ID: 2526352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional displacement by sulpiride of [3H]spiperone binding in vivo. Biochemical and behavioural evidence for a preferential action of limbic and nigral dopamine receptors.
    Köhler C; Ogren SO; Haglund L; Angeby T
    Neurosci Lett; 1979 Jun; 13(1):51-6. PubMed ID: 572522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of [3H]quinpirole binding to D2-like dopamine receptors in rat brain.
    Levant B; Grigoriadis DE; DeSouza EB
    J Pharmacol Exp Ther; 1992 Sep; 262(3):929-35. PubMed ID: 1356154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute reserpine treatment induces down regulation of D-1 dopamine receptor associated adenylyl cyclase activity in rat striatum.
    Thomas KL; Rose S; Jenner P; Marsden CD
    Biochem Pharmacol; 1992 Jul; 44(1):83-91. PubMed ID: 1321631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional recovery of supersensitive dopamine receptors after intrastriatal grafts of fetal substantia nigra.
    Dawson TM; Dawson VL; Gage FH; Fisher LJ; Hunt MA; Wamsley JK
    Exp Neurol; 1991 Mar; 111(3):282-92. PubMed ID: 1825638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of acute and chronic treatments with clozapine and haloperidol on serotonin (5-HT2) and dopamine (D2) receptors in the rat brain.
    Wilmot CA; Szczepanik AM
    Brain Res; 1989 May; 487(2):288-98. PubMed ID: 2525063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of dopamine receptor sites labeled by [3H]-S-sulpiride and [3H]-spiperone in striatum.
    Zahniser NR; Dubocovich ML
    J Pharmacol Exp Ther; 1983 Dec; 227(3):592-9. PubMed ID: 6655559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative analysis of [3H]spiroperidol binding to rat forebrain sections: plasticity of neostriatal dopamine receptors after nigrostriatal injury.
    Neve KA; Altar CA; Wong CA; Marshall JF
    Brain Res; 1984 Jun; 302(1):9-18. PubMed ID: 6428705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective labelling of dopamine (D2) receptors in rat striatum by [3H]domperidone but not by [3H]spiperone.
    Lazareno S; Nahorski SR
    Eur J Pharmacol; 1982 Jul; 81(2):273-85. PubMed ID: 7117377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoradiographic identification of D1 dopamine receptors labelled with [3H]dopamine: distribution, regulation and relationship to coupling.
    Hervé D; Trovero F; Blanc G; Glowinski J; Tassin JP
    Neuroscience; 1992; 46(3):687-700. PubMed ID: 1532052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of inhibitory activity of sulpiride for synaptic [3H]-spiperone binding in the rat striatum.
    Oki K; Nomura Y
    Dev Neurosci; 1982; 5(4):379-84. PubMed ID: 7140585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential alterations in striatal dopamine receptor sensitivity induced by repeated administration of clinically equivalent doses of haloperidol, sulpiride or clozapine in rats.
    Rupniak NM; Kilpatrick G; Hall MD; Jenner P; Marsden CD
    Psychopharmacology (Berl); 1984; 84(4):512-9. PubMed ID: 6441952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lateralization of striatal dopamine (D2) receptors in normal rats.
    Schneider LH; Murphy RB; Coons EE
    Neurosci Lett; 1982 Dec; 33(3):281-4. PubMed ID: 7162690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pituitary and brain D2 receptor density measured in vitro and in vivo in EEDQ treated male rats.
    Ekman A; Eriksson E
    Life Sci; 1991; 48(4):321-31. PubMed ID: 1824955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.